Board/Management Information • Feb 12, 2016
Board/Management Information
Open in ViewerOpens in native device viewer
Novozymes informs that Eivind Kolding will not seek election to the Board of Directors at the upcoming annual shareholders' meeting February 24, 2016, as otherwise announced in the notice to the annual shareholders' meeting.
Novozymes' Board of Directors will not propose the election of another candidate instead of Eivind Kolding. As a consequence, Novozymes' Board of Directors proposes the following candidates for the Board of Directors at the annual shareholders' meeting February 24, 2016:
February 12, 2016 Company announcement No. 5
Contact information [email protected]
Thomas Bomhoff (DK) +45 3077 1226 [email protected]
Klaus Sindahl (DK) +45 5363 0134 [email protected]
Martin Riise (USA) +1 919 649 2565 [email protected]
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 Novozymes A/S CVR number: 10 00 71 27 Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.